Our Mission:

To save lives and improve community health through research & innovation, delivering devices & solutions that provide diagnostics & screening at the point of care.

Our Mission

Why Breath?

Research Products

Research Products

Statistics

A RESEARCH, DEVELOPMENT & DEVICE COMPANY FOCUSED ON PORTABLE BREATH-BASED DIAGNOSTIC & SCREENING APPLICATIONS

FDA EUA GRANTED 4/14/2022 – EUA202006

Founded in 2017, InspectIR Systems is at the forefront of the identification and quantification of breath-based VOCs (volatile organic compounds). Utilizing patented technology, proprietary software & machine learning InspectIR is focused on the development of diagnostic & screening instruments for use in clinical, professional & industrial settings.

Experts agree, breath is the future of health screening. In a crowded industry only InspectIR Systems has received FDA authorization of any level, receiving Emergency Use Authorization (EUA) on April 1thth, 2022. The InspectIR methodology is proven effective & will continue to evolve, proving application in multiple scenarios. 

Leveraging Proven Science to Monitor Health & Wellness

InspectIR is the only testing methodology that does not create cross reactivity, which leads to pre-analytical error, based on adding a solvent.

VIRAL SCREENING

This is front side content.

Back Title

Utilizing patented breath collection to blah...blah...blah

OPIOID TESTING

This is front side content.

Back Title

Utilizing patented breath collection to blah...blah...blah

CANNABIS TESTING

This is front side content.

Back Title

Utilizing patented breath collection to blah...blah...blah

COLLECT SAMPLE

Subject Exhales through their mouth into a tube connected to the PNY-1000.

ANALYSIS

Patent issued measurement process runs, allowing identification & quantification of markers.

RESULTS

PNY-1000 analyzes and displays results utilizing proprietary software.

A Very Different Look at COVID-19

InspectIR is the only testing methodology that does not create cross reactivity, which leads to pre- analytical error, based on adding a solvent or another reagent to bind to a specimen for analysis.

There is also no storage of any biologic material in the InspectIR test.

What makes us different:

  • Chemical-lab-in-a-box: we are analyzing breath via mass spectrometry.
  • InspectIR is the first company to make a commercially available miniature mass spectrometer to analyze breath samples directly.
LEARN MORE

InspectIR PNY-1000 COVID Testing Demo

InspectIR is the only testing methodology that does not create cross reactivity, which leads to pre-analytical error, based on adding a solvent or another reagent to bind to a specimen for analysis. There is also no storage of any biologic material in the InspectIR test.

Total Estimated Time to Test: 3 Mintues

The COVID-19 pandemic has thrown our world into a state of unknown. Like many, InspectIR Systems asked “how can we help?” and began the necessary research. The results have been outstanding.

Play Video
COLLECT SAMPLE

Subject Exhales through their mouth into a tube connected to a test kit, much like blowing up a balloon.

CHEMISTRY

Chemistry in the subject’s breath is captured on the patented inspector systems device.

ANALYSIS

Patent issued measurement process runs, allowing identification & qualification of COVID-19 markers & spectrometry.

RESULTS

Inspect-ir systems device analyzes and displays results utilizing proprietary software.

The Numbers Never Lie

InspectIR is the only testing methodology that does not create cross reactivity, which leads to pre-analytical error, based on adding a solvent.
0
STATES WITH LEGALIZATION OF MEDICAL & RECREATIONAL CANNABIS
0
DEATHS DAILY FROM OPIOID-RELATED OVERDOSES
0
2016 OPIOID OVERDOSE DEATHS
0
VIABLE NON-INVASIVE DETECTION TOOLS AVAILABLE TODAY

InspectIR in the News

logo-mask

Our Team Members

LUCY WRIGHT

Inspect IR Team

LUCY WRIGHT

Inspect IR Team

LUCY WRIGHT

Inspect IR Team

LUCY WRIGHT

Inspect IR Team

Contact InspectIR Systems, LLC

InspectIR is in rapid growth mode. Interested in learning more? Complete the form below & a member of our team will be in touch shortly,